5032/CRUK_/Cancer Research UK/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2008	2
2010	1
2011	1
2012	2
2013	1
2014	1
2015	3
2016	3
2018	1
2019	2
2020	7
2021	4
2024	0

1

Key steps for effective breast cancer prevention.

Britt KL, Cuzick J, Phillips KA. Britt KL, et al. Nat Rev Cancer. 2020 Aug;20(8):417-436. doi: 10.1038/s41568-020-0266-x. Epub 2020 Jun 11. Nat Rev Cancer. 2020. PMID: 32528185 Review.

2

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet. 2015 Oct 3;386(10001):1341-1352. doi: 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23. Lancet. 2015. PMID: 26211827 Free article.

3

Preventive therapy for breast cancer.

Sestak I, Cuzick J. Sestak I, et al. Curr Oncol Rep. 2012 Dec;14(6):568-73. doi: 10.1007/s11912-012-0273-5. Curr Oncol Rep. 2012. PMID: 22972612

4

Differing Perspectives on Breast Cancer Chemoprevention.

Cuzick J, Wickerham L, Powles T. Cuzick J, et al. JAMA Oncol. 2016 Feb;2(2):276-7. doi: 10.1001/jamaoncol.2015.4406. JAMA Oncol. 2016. PMID: 26869000 No abstract available.

5

Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial.

Sestak I, Blake G, Patel R, Cuzick J, Howell A, Coleman R, Eastell R. Sestak I, et al. Br J Cancer. 2021 Apr;124(8):1373-1378. doi: 10.1038/s41416-020-01228-2. Epub 2021 Jan 22. Br J Cancer. 2021. PMID: 33495601 Free PMC article.

6

Calibration of CTS5 in Women With Early Estrogen Receptor-Positive Breast Cancer.

Dowsett M, Sestak I, Cuzick J. Dowsett M, et al. J Clin Oncol. 2021 Feb 1;39(4):338-339. doi: 10.1200/JCO.20.02551. Epub 2020 Dec 16. J Clin Oncol. 2021. PMID: 33326252 No abstract available.

7

Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II.

Sestak I, Smith SG, Howell A, Forbes JF, Cuzick J. Sestak I, et al. Ann Oncol. 2018 Feb 1;29(2):504-509. doi: 10.1093/annonc/mdx713. Ann Oncol. 2018. PMID: 29126161 Free PMC article. Clinical Trial.

8

External validation of a mammographic texture marker for breast cancer risk in a case-control study.

Wang C, Brentnall AR, Mainprize J, Yaffe M, Cuzick J, Harvey JA. Wang C, et al. J Med Imaging (Bellingham). 2020 Jan;7(1):014003. doi: 10.1117/1.JMI.7.1.014003. Epub 2020 Feb 12. J Med Imaging (Bellingham). 2020. PMID: 32064299 Free PMC article.

9

IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole.

Cuzick J. Cuzick J. Expert Rev Anticancer Ther. 2008 Sep;8(9):1377-85. doi: 10.1586/14737140.8.9.1377. Expert Rev Anticancer Ther. 2008. PMID: 18759690

10

Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole.

Singh S, Cuzick J, Mesher D, Richmond B, Howell A. Singh S, et al. Breast Cancer Res Treat. 2012 Apr;132(2):625-9. doi: 10.1007/s10549-011-1911-6. Epub 2011 Dec 25. Breast Cancer Res Treat. 2012. PMID: 22198469 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year